China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $17 | $18 | $14 | $19 |
| % Growth | -8.9% | 26.7% | -24.9% | – |
| Cost of Goods Sold | $9 | $9 | $7 | $7 |
| Gross Profit | $8 | $9 | $7 | $12 |
| % Margin | 47.6% | 51.2% | 50.3% | 62.1% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $6 | $7 | $6 | $9 |
| Sales & Mktg Exp. | $5 | $6 | $5 | $8 |
| Other Operating Expenses | $0 | -$0 | -$0 | -$0 |
| Operating Expenses | $8 | $8 | $6 | $9 |
| Operating Income | $0 | $1 | $1 | $3 |
| % Margin | 2% | 7.9% | 7.4% | 14.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $1 | $1 | $3 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | $1 | $1 | $2 |
| % Margin | 0.3% | 7.1% | 5.3% | 10.1% |
| EPS | 0.011 | 0.26 | 0.15 | 0.38 |
| % Growth | -95.9% | 73.3% | -60.5% | – |
| EPS Diluted | 0.011 | 0.26 | 0.15 | 0.38 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $2 | $3 | $2 | $4 |
| % Margin | 9.3% | 14.1% | 15.1% | 18.9% |